ArticleAmerican journal of translational research2021

Efficacy and safety of neoadjuvant chemoradiotherapy plus apatinib for patients with locally advanced, HER2-negative, Siewert's type II-III adenocarcinoma of esophagogastric junction: a single-arm, open-label, phase II trial.

Honghai Guo et al.PubMed ↗Full text ↗

No numbers read from the abstract.